Drug Trial Radar · NCT01592786
An Open-Label Safety Study of Memantine in Pediatric Patients With Autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Last checked: Nov 20, 2026Latest source record: Aug 7, 2014 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
906
Actual
Start
Jun 2012
Primary completion
Jul 2013
Study completion Aug 2013
Sponsor
- Lead sponsor
- Forest LaboratoriesAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- May 7, 2012
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 6 years, up to 12 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The purpose of this study is to evaluate the safety and tolerability of memantine in pediatric (6-12 years old) patients with autism, Asperger's Disorder, or Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS) and to identify responders for participation in a follow-up randomized withdrawal study.
Conditions
- Autism Spectrum Disorder (ASD)
- Autism
- Autistic Disorder
- Asperger's Disorder
- Asperger's
- Pediatric Autism
- Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS)
Interventions
Memantine Hydrochloride (HCl)Drug
Memantine extended release 3-mg capsules; the dosages studied ranged from 3 - 15 mg/day; weight based dosing in 4 weight groups; oral administration. Dosing is once daily for up to 48 weeks.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Confirmed Social Responsiveness Scale (SRS) RespondersTime frame: Visit 1 (Baseline) to Visit 8 (week 48/Final Visit)
Locations
118 sites in 18 countries. Site status is shown where the registry gives one.
Forest Investigative Site 068
Dothan, Alabama
Forest Investigative Site 005
Phoenix, Arizona
Forest Investigative Site 055
Tucson, Arizona
Forest Investigative Site 077
Little Rock, Arkansas
Forest Investigative Site 054
Glendale, California
Forest Investigative Site 109
Imperial, California
Forest Investigative Site 066
Irvine, California
Forest Investigative Site 096
Los Angeles, California
Forest Investigative Site 021
San Francisco, California
Forest Investigative Site 026
Santa Ana, California
Forest Investigative Site 002
Stanford, California
Forest Investigative Site 078
Boulder, Colorado
Forest Investigative Site 073
Centennial, Colorado
Forest Investigative Site 052
Washington D.C., District of Columbia
Forest Investigative Site 075
Bradenton, Florida
Forest Investigative Site 080
Gainesville, Florida
Forest Investigative Site 117
Jacksonville, Florida
Forest Investigative Site 065
Maitland, Florida
Forest Investigative Site 118
Miami, Florida
Forest Investigative Site 085
Oakland Park, Florida
Forest Investigative Site 115
Orange City, Florida
Forest Investigative Site 124
Orlando, Florida
Forest Investigative Site 125
Orlando, Florida
Forest Investigative Site 062
Orlando, Florida
Forest Investigative Site 114
Orlando, Florida
Forest Investigative Site 067
Tampa, Florida
Forest Investigative Site 101
Wellington, Florida
Forest Investigative Site 102
Libertyville, Illinois
Forest Investigative Site 023
Naperville, Illinois
Forest Investigative Site 082
Evansville, Indiana
Forest Investigative Site 123
Fort Wayne, Indiana
Forest Investigative Site 056
Indianapolis, Indiana
Forest Investigative Site 084
Indianapolis, Indiana
Forest Investigative Site 106
Wichita, Kansas
Forest Investigative Site 061
Louisville, Kentucky
Forest Investigative Site 074
Owensboro, Kentucky
Forest Investigative Site 095
Lake Charles, Louisiana
Forest Investigative Site 091
New Orleans, Louisiana
Forest Investigative Site 086
Rockville, Maryland
Forest Investigative Site 059
Newton, Massachusetts
Showing 40 of 118 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.